{"meta":{"query_hash":"5cd2874a96c1","filters":{"venue":"Cancer Management and Research"},"cohort_total":36,"direct_labels_cover":0,"predictions_cover":36,"exported":36,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/5cd2874a96c1","api":"https://metacan.xera.ac/api/v1/cohort?venue=Cancer+Management+and+Research"},"results":[{"id":"W1518371015","doi":"10.2147/cmar.s64165","title":"The impact of mindfulness-based interventions on symptom burden, positive psychological outcomes, and biomarkers in cancer patients","year":2015,"lang":"en","type":"review","venue":"Cancer Management and Research","topic":"Mindfulness and Compassion Interventions","field":"Psychology","cited_by":151,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"University of Calgary; Cumming School of Medicine, University of Calgary; Alberta Innovates; Alberta Innovates - Health Solutions; Canadian Institutes of Health Research; Alberta Cancer Foundation","keywords":"Mindfulness; Psychological intervention; Psychosocial; Clinical psychology; Psychology; Quality of life (healthcare); Medicine; Cancer; Mindfulness-based stress reduction; Disease; Psychotherapist; Psychiatry","score_opus":0.21626519577523604,"score_gpt":0.5580148776312327,"score_spread":0.34174968185599663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1518371015","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00060881913,0.99903166,0.00003475775,0.000082194,0.000032379838,0.000010583757,0.000008963117,0.0000020965126,0.0001885008],"genre_scores_gemma":[0.0067617917,0.9927449,0.00020082454,0.00012644469,0.00004694674,0.000027662254,0.00001592224,0.0000011164676,0.00007432011],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99955565,0.00017972225,0.000087973545,0.000054483546,0.000097418895,0.00002471187],"domain_scores_gemma":[0.9988411,0.00094815705,0.00011253255,0.000014849177,0.00006035993,0.000023007566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011467153,0.00061527506,0.0014774681,0.0014705195,0.00018059743,0.0007088245,0.00062664406,0.00088237517,0.0014432954],"category_scores_gemma":[0.0033968948,0.00021782069,0.001219644,0.0011385183,0.00027529092,0.0005114446,0.0005238301,0.0008024823,0.00015039422],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021167709,0.000111227106,0.00035466827,0.14628369,0.001259007,0.00004734212,0.00016827609,0.00015986167,0.00066000636,0.00059311924,0.0022850393,0.84786606],"study_design_scores_gemma":[0.0009016881,0.003052991,0.046853032,0.46868572,0.025102168,0.0037848903,0.0012847927,0.00081111427,0.0038862869,0.004761108,0.44073874,0.00013755298],"about_ca_topic_score_codex":0.0012226886,"about_ca_topic_score_gemma":0.002356765,"teacher_disagreement_score":0.0014774681,"about_ca_system_score_codex":0.00042514817,"about_ca_system_score_gemma":0.0009388608,"threshold_uncertainty_score":0.0060644746},"labels":[],"label_agreement":null},{"id":"W2052956903","doi":"10.2147/cmar.s52217","title":"Proactive strategies for regorafenib in metastatic colorectal cancer: implications for optimal patient management","year":2014,"lang":"en","type":"review","venue":"Cancer Management and Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Bayer HealthCare","keywords":"Regorafenib; Medicine; Colorectal cancer; Bevacizumab; Adverse effect; Oncology; Internal medicine; Irinotecan; Aflibercept; Cancer; Chemotherapy","score_opus":0.1807651006745937,"score_gpt":0.49403896804556896,"score_spread":0.3132738673709753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052956903","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005106245,0.75177664,0.007804337,0.21882133,0.0032043601,0.0001750657,0.00009934301,0.00019486844,0.012817863],"genre_scores_gemma":[0.06925626,0.8121556,0.02777781,0.07769213,0.007843033,0.00071259344,0.0002708409,0.000052877956,0.0042389072],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983407,0.00090481376,0.00020484265,0.000119407116,0.0003085928,0.00012161042],"domain_scores_gemma":[0.99716127,0.0014078831,0.00042432544,0.00005659275,0.0005128216,0.0004370708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035671347,0.0004959355,0.0011404429,0.00047305258,0.0007561528,0.0022033616,0.00097029447,0.0017947911,0.0020818443],"category_scores_gemma":[0.0070775887,0.0001800795,0.0008956647,0.00036560275,0.00070549466,0.0023372287,0.0014350831,0.0055678887,0.00067371584],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032481068,0.00039345052,0.003829854,0.006566671,0.00034999038,0.0013927405,0.0009892095,0.0018665529,0.0014448211,0.015571732,0.13700548,0.8302646],"study_design_scores_gemma":[0.00049465755,0.0006597186,0.008362597,0.017663643,0.00048996345,0.0034489431,0.0023082902,0.0015437107,0.0009280608,0.031263992,0.9326911,0.00014521742],"about_ca_topic_score_codex":0.0013948114,"about_ca_topic_score_gemma":0.004154803,"teacher_disagreement_score":0.0035671347,"about_ca_system_score_codex":0.0013556541,"about_ca_system_score_gemma":0.004030546,"threshold_uncertainty_score":0.01886499},"labels":[],"label_agreement":null},{"id":"W2058437641","doi":"10.2147/cmar.s44940","title":"Single fraction radiotherapy versus multiple fraction radiotherapy for bone metastases in prostate cancer patients: comparative effectiveness","year":2014,"lang":"en","type":"review","venue":"Cancer Management and Research","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Royal Victoria Regional Health Centre","funders":"","keywords":"Radiation therapy; Medicine; Prostate cancer; External beam radiotherapy; Prostate; Cancer; Oncology; Radiology; Internal medicine","score_opus":0.16090454644737245,"score_gpt":0.48281872684940896,"score_spread":0.3219141804020365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058437641","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013186504,0.9979723,0.00006229464,0.00008744087,0.00007792454,0.000075906224,0.00007733988,0.0000021724518,0.00032603252],"genre_scores_gemma":[0.030832002,0.9679842,0.00044657732,0.00022388261,0.00013765451,0.00015093137,0.00010701657,0.0000023563628,0.00011537993],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.996203,0.0021444424,0.00078808423,0.00024492625,0.0005405329,0.0000789608],"domain_scores_gemma":[0.99161667,0.0066495463,0.001125144,0.00009041989,0.00042428102,0.00009393962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005800684,0.0009176181,0.0058470108,0.00266078,0.00022527645,0.0014338414,0.0009607684,0.0011967551,0.004738896],"category_scores_gemma":[0.014936636,0.0003882879,0.006927499,0.0030229837,0.00047164553,0.00087094447,0.0005398222,0.001231671,0.00019343659],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069981925,0.0001471792,0.0012615038,0.7484289,0.0741109,0.00008116667,0.00009998382,0.00045704504,0.00043946886,0.0009746035,0.0016933624,0.16530769],"study_design_scores_gemma":[0.01208936,0.006137951,0.014100512,0.3148025,0.6067102,0.00088484405,0.00037173685,0.00063348166,0.0011535266,0.0022921895,0.040721316,0.0001024318],"about_ca_topic_score_codex":0.0017605678,"about_ca_topic_score_gemma":0.0039786026,"teacher_disagreement_score":0.0058470108,"about_ca_system_score_codex":0.0015413066,"about_ca_system_score_gemma":0.002015298,"threshold_uncertainty_score":0.030677319},"labels":[],"label_agreement":null},{"id":"W2587591803","doi":"10.2147/cmar.s117703","title":"Feasibility of an exercise intervention for fatigued breast cancer patients at a community-based cardiac rehabilitation program","year":2017,"lang":"en","type":"article","venue":"Cancer Management and Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lawson Health Research Institute; Fanshawe College; Western University","funders":"","keywords":"Breast cancer; Rehabilitation; Medicine; Physical therapy; Intervention (counseling); Physical medicine and rehabilitation; Cancer; Internal medicine; Nursing","score_opus":0.1102782766174919,"score_gpt":0.46296892544021934,"score_spread":0.35269064882272744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587591803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983462,0.00005673408,0.00015279115,0.00017439482,0.000011236139,0.0007733758,0.000026159085,0.000015982756,0.00044310212],"genre_scores_gemma":[0.9963403,0.0000949521,0.0013881378,0.00019506163,0.00005337186,0.0014889357,0.000099932804,0.000002160126,0.00033714835],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99946004,0.0002568298,0.000030549,0.000049996514,0.000066257555,0.00013639231],"domain_scores_gemma":[0.9990721,0.00016693659,0.00010953347,0.00003295312,0.000085604406,0.00053282076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010413616,0.0003408556,0.00029400366,0.00039381205,0.0006895879,0.0002438468,0.00042482003,0.0006019257,0.0037657823],"category_scores_gemma":[0.0020980712,0.00019466219,0.00039115796,0.00017581866,0.00019814113,0.00022537485,0.00059890136,0.00057145406,0.0003749845],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033957094,0.21895342,0.23694552,0.0007942547,0.0002745782,0.0008237496,0.0016069715,0.0017162856,0.016650904,0.0000828984,0.0019914086,0.48620287],"study_design_scores_gemma":[0.018518243,0.18570894,0.78755796,0.00019266363,0.00022029332,0.00036698315,0.00075800257,0.0027232603,0.0016729899,0.00006846651,0.0021764515,0.000035748424],"about_ca_topic_score_codex":0.0019412669,"about_ca_topic_score_gemma":0.0041669407,"teacher_disagreement_score":0.0037657823,"about_ca_system_score_codex":0.00032215257,"about_ca_system_score_gemma":0.0015417271,"threshold_uncertainty_score":0.012597799},"labels":[],"label_agreement":null},{"id":"W2592549712","doi":"10.2147/cmar.s94059","title":"New developments in the management of Waldenström macroglobulinemia","year":2017,"lang":"en","type":"review","venue":"Cancer Management and Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ibrutinib; Lymphoplasmacytic Lymphoma; Waldenstrom macroglobulinemia; Medicine; Macroglobulinemia; Lymphoma; Hematology; Internal medicine; Lenalidomide; Oncology; Leukemia; Multiple myeloma; Chronic lymphocytic leukemia","score_opus":0.37549665901824836,"score_gpt":0.5471592874097043,"score_spread":0.17166262839145596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592549712","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014669831,0.998538,0.00006257134,0.00028297555,0.0001224961,0.0000031792563,0.000012929503,0.0000054990173,0.0008256531],"genre_scores_gemma":[0.00080438296,0.9983747,0.00014446961,0.0001917977,0.00014049561,0.000003884787,0.000024753532,0.0000010876795,0.00031434986],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998348,0.000028592352,0.0000308113,0.000025425765,0.000062763356,0.00001754054],"domain_scores_gemma":[0.9997534,0.00011181595,0.000040666608,0.000006062714,0.00006071309,0.000027417569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004858845,0.00044166282,0.0008994071,0.0020730204,0.00024928362,0.00076789473,0.0005826631,0.00070037897,0.0031105382],"category_scores_gemma":[0.0006375751,0.00016483801,0.00047128487,0.0014316114,0.00031499003,0.000988085,0.00047902478,0.0017092419,0.0012804137],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006289691,0.0000623426,0.0002072539,0.012921692,0.00006644765,0.00027180783,0.00007703174,0.00025851827,0.0010477431,0.0027368711,0.020181665,0.9621058],"study_design_scores_gemma":[0.000021751757,0.00010357083,0.0008153584,0.0037908305,0.00011105097,0.001746355,0.00007582905,0.00007168389,0.0003246473,0.0011427181,0.99178183,0.000014491146],"about_ca_topic_score_codex":0.0009987111,"about_ca_topic_score_gemma":0.0025341867,"teacher_disagreement_score":0.0031105382,"about_ca_system_score_codex":0.00047275325,"about_ca_system_score_gemma":0.0007974712,"threshold_uncertainty_score":0.010405779},"labels":[],"label_agreement":null},{"id":"W2636581712","doi":"10.2147/cmar.s95663","title":"Management of malignant pleural effusion: challenges and solutions","year":2017,"lang":"en","type":"review","venue":"Cancer Management and Research","topic":"Pleural and Pulmonary Diseases","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Saskatchewan","funders":"Marie Curie","keywords":"Medicine; Malignant pleural effusion; Intensive care medicine; Pleural effusion; Quality of life (healthcare); Systemic therapy; Cohort; Cancer; Palliative care; Surgery; Internal medicine; Breast cancer","score_opus":0.46753351139392424,"score_gpt":0.4917667994251016,"score_spread":0.024233288031177358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2636581712","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011063677,0.99567944,0.00014989168,0.0033150795,0.0002006201,0.0000050896797,0.000012235127,0.0000043591585,0.00052264775],"genre_scores_gemma":[0.001094546,0.99741864,0.00035221913,0.00063179317,0.0003535353,0.000007717098,0.000015198947,0.0000014321478,0.00012484234],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99898225,0.00034774866,0.00022094081,0.00009242775,0.00030226744,0.000054361695],"domain_scores_gemma":[0.9975969,0.0014955405,0.00031061372,0.000041163585,0.000456671,0.000099124656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002151199,0.0006148445,0.0015939,0.002061107,0.00039006205,0.0021654065,0.0011274553,0.0019000599,0.0035934455],"category_scores_gemma":[0.0058042817,0.00022930898,0.0010707709,0.0017516027,0.0007442477,0.0025527936,0.0009771916,0.0024481053,0.00093288306],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005507444,0.000068650304,0.0005586036,0.036647536,0.00021203737,0.00035061053,0.00016541054,0.0005272164,0.00029387508,0.008067784,0.031871513,0.9211816],"study_design_scores_gemma":[0.000049530205,0.00016054399,0.0023029665,0.08357123,0.0005440304,0.0038445294,0.0008066595,0.00045511872,0.0002365292,0.014759804,0.89320767,0.000061351035],"about_ca_topic_score_codex":0.001586579,"about_ca_topic_score_gemma":0.0031114654,"teacher_disagreement_score":0.0035934455,"about_ca_system_score_codex":0.0009840722,"about_ca_system_score_gemma":0.0032897352,"threshold_uncertainty_score":0.012021244},"labels":[],"label_agreement":null},{"id":"W2738825067","doi":"10.2147/cmar.s139945","title":"Exploring the acceptability of human papillomavirus self-sampling among Muslim immigrant women","year":2017,"lang":"en","type":"article","venue":"Cancer Management and Research","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Metropolitan University; Institute for Clinical Evaluative Sciences; University of Toronto","funders":"Canadian Cancer Society Research Institute; University of Toronto","keywords":"Immigration; Cervical cancer; Medicine; Family medicine; Human papillomavirus; Cervical screening; Community health; Gynecology; Demography; Gerontology; Cancer; Nursing; Public health; Geography; Sociology; Internal medicine","score_opus":0.3283148503672061,"score_gpt":0.4665383361897651,"score_spread":0.138223485822559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2738825067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986864,0.000085904074,0.00003260815,0.00025222765,0.000004600278,0.000038041366,0.00003912653,0.0000010444702,0.0008600092],"genre_scores_gemma":[0.99920964,0.00018790504,0.000107489854,0.0001949875,0.000003818409,0.00003190831,0.00003319835,7.2326145e-7,0.00023041981],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888295,0.0005026852,0.00006790462,0.000053889995,0.0002865161,0.00020615222],"domain_scores_gemma":[0.99781764,0.0006513516,0.000469027,0.00007920094,0.00059357163,0.00038926373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028362211,0.0001778806,0.00019012977,0.00026840632,0.0014310532,0.0008827602,0.0004231621,0.0003840921,0.0021718978],"category_scores_gemma":[0.007845853,0.00015251407,0.00031705233,0.00028742652,0.0006300981,0.0004005977,0.0007678172,0.00054119056,0.00015524757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022553498,0.00032008157,0.91637343,0.00018197703,0.00004299758,0.0003196795,0.057305887,0.000043819382,0.0009028768,0.0001757038,0.0006566022,0.023451393],"study_design_scores_gemma":[0.000022350909,0.00097036833,0.82408786,0.00027833367,0.000057432357,0.0004030808,0.17045948,0.0005405507,0.00036835944,0.00012297188,0.0026568132,0.000032361517],"about_ca_topic_score_codex":0.1513203,"about_ca_topic_score_gemma":0.1809312,"teacher_disagreement_score":0.1513203,"about_ca_system_score_codex":0.0020140738,"about_ca_system_score_gemma":0.0032515794,"threshold_uncertainty_score":0.300879},"labels":[],"label_agreement":null},{"id":"W2755237455","doi":"10.2147/cmar.s139864","title":"A p53-regulated apoptotic gene signature predicts treatment response and outcome in pediatric acute lymphoblastic leukemia","year":2017,"lang":"en","type":"article","venue":"Cancer Management and Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Mental Health; American Lebanese Syrian Associated Charities; National Institutes of Health; Michael Smith Health Research BC; American Cancer Society","keywords":"Apoptosis; Gene; Gene expression profiling; Gene expression; Gene signature; Lymphoblast; Cancer research; Biology; Phenotype; DNA damage; Leukemia; Tumor suppressor gene; Suppressor; Immunology; Cell culture; Genetics; DNA","score_opus":0.04402698115860732,"score_gpt":0.3682069843544134,"score_spread":0.3241800031958061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755237455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987909,0.00025733354,0.0004305591,0.00001447041,0.0000013496635,0.000006444733,0.00034274807,0.000008626202,0.00014766182],"genre_scores_gemma":[0.9980311,0.00018347829,0.0008189868,0.0000124843655,0.000002801608,0.00001562519,0.00079512194,0.0000037415361,0.00013654128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998987,0.00001997319,0.000008604843,0.000023466757,0.000028455635,0.00002076907],"domain_scores_gemma":[0.9996997,0.00007645375,0.00013177209,0.0000119841525,0.00003705667,0.000043060227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015928084,0.0001494403,0.00022171195,0.0004919708,0.00008613887,0.00020770934,0.00009822287,0.00015161494,0.00066784],"category_scores_gemma":[0.0005635854,0.00006642672,0.00010264294,0.0006343476,0.00013883787,0.00014392174,0.00012440151,0.00021850274,0.00012546116],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014016413,0.00009239009,0.8788904,0.00008787737,0.00006474143,0.00021720944,0.00008210835,0.0009910116,0.09946205,0.00005191395,0.0002803721,0.01837825],"study_design_scores_gemma":[0.000010829066,0.00022666401,0.9833362,0.000006439641,0.00003438432,0.0006819771,0.000081985156,0.0015543308,0.0136152515,0.00006066604,0.0003878467,0.000003416641],"about_ca_topic_score_codex":0.0006095617,"about_ca_topic_score_gemma":0.00086978707,"teacher_disagreement_score":0.00066784,"about_ca_system_score_codex":0.00026370655,"about_ca_system_score_gemma":0.00014795721,"threshold_uncertainty_score":0.002234161},"labels":[],"label_agreement":null},{"id":"W2764041747","doi":"10.2147/cmar.s147054","title":"A structured group exercise program for patients with metastatic cancer receiving chemotherapy and CTNNB1 (β-catenin) as a biomarker of exercise efficacy","year":2017,"lang":"en","type":"article","venue":"Cancer Management and Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada); The Scarborough Hospital","funders":"","keywords":"Biomarker; Medicine; Chemotherapy; Oncology; BETA (programming language); Internal medicine; Cancer; Biology; Computer science","score_opus":0.058920961300217976,"score_gpt":0.40242007612765857,"score_spread":0.3434991148274406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2764041747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99882406,0.00012417838,0.00017225866,0.00009012149,0.000012164324,0.00047715727,0.00004273944,0.000013739546,0.00024353138],"genre_scores_gemma":[0.99685943,0.00012824338,0.0010857714,0.00010274627,0.00005130256,0.0013707841,0.00014488926,0.0000011359188,0.00025565707],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99973804,0.00012551654,0.000017002018,0.000046494744,0.000032414693,0.000040522544],"domain_scores_gemma":[0.99942625,0.00012127692,0.00011191674,0.00002789949,0.000025591735,0.00028713158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005846822,0.0004146081,0.0006208242,0.00027856,0.00027192716,0.00014859358,0.0002675379,0.000446902,0.0027024571],"category_scores_gemma":[0.0011210329,0.00012630814,0.0003098705,0.0001922132,0.00019577192,0.00018919192,0.00038507432,0.00040326832,0.00026676664],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1612997,0.18527383,0.20697007,0.0015188883,0.0008571847,0.0004886437,0.0011148176,0.0027461252,0.025335336,0.00013985077,0.0022440213,0.4120116],"study_design_scores_gemma":[0.038104687,0.522955,0.4328234,0.00010651099,0.000300407,0.00021050897,0.00022175901,0.0026965083,0.0014533267,0.00012517489,0.0009802296,0.000022474964],"about_ca_topic_score_codex":0.00045034243,"about_ca_topic_score_gemma":0.0010327224,"teacher_disagreement_score":0.0027024571,"about_ca_system_score_codex":0.00015959036,"about_ca_system_score_gemma":0.00047442853,"threshold_uncertainty_score":0.009040594},"labels":[],"label_agreement":null},{"id":"W2770169340","doi":"10.2147/cmar.s147326","title":"Checkpoint blockade in solid tumors and B-cell malignancies, with special consideration of the role of CD200","year":2017,"lang":"en","type":"review","venue":"Cancer Management and Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Blockade; Immune checkpoint; Cancer research; Cancer; Immune system; Immunology; Biology; Medicine; Immunotherapy; Receptor; Internal medicine","score_opus":0.09535184495420482,"score_gpt":0.4029308205727563,"score_spread":0.3075789756185515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770169340","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035298213,0.9922651,0.0007103686,0.0003903484,0.00019907235,0.000012940037,0.00003075048,0.0000286355,0.0028330607],"genre_scores_gemma":[0.020986978,0.9748813,0.0009047788,0.0004919047,0.00039125004,0.000020935855,0.00010999564,0.000005519644,0.0022073502],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99994326,0.000010026487,0.0000071367863,0.000010261518,0.000020615125,0.000008671734],"domain_scores_gemma":[0.9999577,0.000019400004,0.000009860007,0.0000018769651,0.000005869089,0.000005336105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013760569,0.00026622266,0.00037833824,0.00042039785,0.00010842639,0.00035218702,0.00026193148,0.00033768508,0.0011728018],"category_scores_gemma":[0.00013361059,0.00004581028,0.00019412243,0.0003729794,0.00014463009,0.00031850656,0.00022651881,0.0005873974,0.00044729194],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001618564,0.00008510789,0.00029645403,0.006689005,0.000059984388,0.00034636536,0.000051200954,0.00042515105,0.027122522,0.0028238667,0.008778719,0.9531597],"study_design_scores_gemma":[0.000068624235,0.0012308691,0.0031250052,0.0012800588,0.00019361444,0.005231031,0.00008762504,0.00028423403,0.018968629,0.0030999263,0.9664088,0.000021620364],"about_ca_topic_score_codex":0.00023308586,"about_ca_topic_score_gemma":0.00064263435,"teacher_disagreement_score":0.0011728018,"about_ca_system_score_codex":0.00021473106,"about_ca_system_score_gemma":0.0002591108,"threshold_uncertainty_score":0.003923416},"labels":[],"label_agreement":null},{"id":"W2791699872","doi":"10.2147/cmar.s155283","title":"<em>MC1R</em> variants as melanoma risk factors independent of at-risk phenotypic characteristics: a pooled analysis from the M-SKIP project","year":2018,"lang":"en","type":"article","venue":"Cancer Management and Research","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"School of Medicine, New York University; National Institutes of Health; Universiteit Leiden; Università degli Studi dell'Aquila; Karolinska Institutet; National and Kapodistrian University of Athens; Deutsches Krebsforschungszentrum; Institute of Management Research, College of Business Administration Seoul National University; Pomorski Uniwersytet Medyczny W Szczecinie; Associazione Italiana per la Ricerca sul Cancro; Istituto Oncologico Veneto; Universidad de Murcia; Murdoch Children's Research Institute; Università degli Studi di Genova; INCLIVA Instituto de Investigación Sanitaria; University of Leeds; York University; London School of Hygiene and Tropical Medicine; Children’s Hospital of Wisconsin Research Institute; Leids Universitair Medisch Centrum; National Cancer Institute; Menzies Institute for Medical Research; Yale University; Moffitt Cancer Center; University of Ottawa; University of Minnesota; Cancer Research UK","keywords":"Melanoma; Phototype; Medicine; Receiver operating characteristic; Genotype; Risk factor; Phenotype; Oncology; Internal medicine; Gene; Genetics; Dermatology; Biology; Cancer research","score_opus":0.0251759070205364,"score_gpt":0.3169187829255286,"score_spread":0.2917428759049922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791699872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89362246,0.08266784,0.011597332,0.00027677332,0.00017343735,0.0004588087,0.009851186,0.00017468233,0.0011775084],"genre_scores_gemma":[0.98872256,0.0035572678,0.002513707,0.000107952204,0.0001235725,0.0003294538,0.0042294227,0.00005493143,0.0003611586],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.98826665,0.0074559934,0.0011232031,0.0019890869,0.000898146,0.0002669139],"domain_scores_gemma":[0.98889685,0.0053281435,0.0022770546,0.0023014485,0.0009179174,0.00027849586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014535763,0.001916927,0.0035336607,0.0020482147,0.00037689882,0.0012536425,0.0009838796,0.00096264534,0.0021300674],"category_scores_gemma":[0.019306064,0.000798173,0.013743529,0.0018725441,0.0003604689,0.0004465958,0.0014820978,0.0005522881,0.0002505343],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029833693,0.000102659826,0.42306474,0.0065709343,0.5152432,0.0005227148,0.0002473051,0.0017564921,0.004015303,0.00024561796,0.0018331821,0.016564237],"study_design_scores_gemma":[0.002016637,0.0023280662,0.48860696,0.0009442557,0.4980263,0.00071450457,0.00016835288,0.002795201,0.0011006275,0.00043376588,0.0027914834,0.000073905954],"about_ca_topic_score_codex":0.0032030696,"about_ca_topic_score_gemma":0.0035187674,"teacher_disagreement_score":0.014535763,"about_ca_system_score_codex":0.00032013314,"about_ca_system_score_gemma":0.0005465262,"threshold_uncertainty_score":0.07687342},"labels":[],"label_agreement":null},{"id":"W2793570480","doi":"10.2147/cmar.s148317","title":"Neoadjuvant chemotherapy among patients treated for nonmetastatic breast cancer in a population with a high HIV prevalence in Johannesburg, South Africa","year":2018,"lang":"en","type":"article","venue":"Cancer Management and Research","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Cancer Institute; Medical Research Council; Cancer Association of South Africa; South African Medical Research Council","keywords":"Medicine; Breast cancer; Chemotherapy; Human immunodeficiency virus (HIV); Oncology; Population; Internal medicine; Cancer; Demography; Gynecology; Environmental health; Family medicine","score_opus":0.022881448145472553,"score_gpt":0.3170786814220852,"score_spread":0.2941972332766126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793570480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996406,0.0000737097,0.000014263163,0.00007810254,0.0000018305263,0.000006909692,0.000048530866,5.542927e-7,0.00013547506],"genre_scores_gemma":[0.99964285,0.00013425056,0.00003381565,0.00003813078,0.000003725116,0.00000946258,0.00005220127,4.5520815e-7,0.00008506233],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998759,0.000032856507,0.000013174635,0.000021909416,0.000018808369,0.000037235706],"domain_scores_gemma":[0.9996667,0.00005452599,0.00020167432,0.0000074970408,0.000015952694,0.000053685555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018407166,0.0001590265,0.00017040955,0.00058771775,0.00049104926,0.00057583046,0.00019932142,0.00020294324,0.0012990612],"category_scores_gemma":[0.0010044039,0.0002726894,0.00013831488,0.0008621094,0.00021876894,0.0004435046,0.00034199466,0.00038223088,0.00013247404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035894293,0.00004390301,0.99683666,0.000014384298,0.000012547308,0.00068195217,0.0006718038,0.000024494826,0.0003699367,0.000023332728,0.0001023503,0.0011827734],"study_design_scores_gemma":[0.000014733945,0.000108593915,0.9931507,0.000028649334,0.000017247952,0.0013487146,0.0044243676,0.00025575573,0.00011252517,0.000035705405,0.00049675856,0.000006195422],"about_ca_topic_score_codex":0.011568646,"about_ca_topic_score_gemma":0.016726648,"teacher_disagreement_score":0.011568646,"about_ca_system_score_codex":0.0005425603,"about_ca_system_score_gemma":0.0005082999,"threshold_uncertainty_score":0.023002625},"labels":[],"label_agreement":null},{"id":"W2800306828","doi":"10.2147/cmar.s162714","title":"Is progression-free survival a more relevant endpoint than overall survival in first-line HR+/HER2− metastatic breast cancer?","year":2018,"lang":"en","type":"article","venue":"Cancer Management and Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"European Society for Medical Oncology","keywords":"Medicine; Metastatic breast cancer; Internal medicine; Oncology; Progression-free survival; Hazard ratio; Clinical endpoint; Breast cancer; Cancer; Observational study; Randomized controlled trial; Quality of life (healthcare); Chemotherapy; Confidence interval","score_opus":0.09342696169412701,"score_gpt":0.42938135925798293,"score_spread":0.3359543975638559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800306828","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038061072,0.9940323,0.0001624846,0.00089052436,0.00016678606,0.00009425553,0.00037266628,0.0000029294486,0.00047195316],"genre_scores_gemma":[0.20389184,0.7876385,0.0014585374,0.0039333706,0.0011756439,0.00085504464,0.00076219585,0.000017134218,0.00026772846],"study_design_codex":"systematic_review","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9878076,0.0057411953,0.0042269337,0.0008526923,0.001223186,0.00014841082],"domain_scores_gemma":[0.9311449,0.051803328,0.013812061,0.0005844043,0.0023358879,0.0003194],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01816128,0.0006121519,0.005515577,0.0040158317,0.0002914509,0.002635696,0.0011869475,0.0018267924,0.0028580718],"category_scores_gemma":[0.05234715,0.00040478565,0.0049276683,0.0052026412,0.0012404739,0.0025395222,0.00073574495,0.0014995493,0.00024389678],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036457235,0.00004785123,0.010780146,0.8502166,0.024540506,0.00013174805,0.0002257104,0.00023675148,0.00035167052,0.000914695,0.0029553408,0.10595319],"study_design_scores_gemma":[0.0049046273,0.0024254324,0.07940346,0.620589,0.21760304,0.0017379229,0.00094841776,0.0005235186,0.0011516558,0.0045434786,0.06596245,0.00020700072],"about_ca_topic_score_codex":0.0020890892,"about_ca_topic_score_gemma":0.0035061862,"teacher_disagreement_score":0.9818387,"about_ca_system_score_codex":0.0020587004,"about_ca_system_score_gemma":0.0025582986,"threshold_uncertainty_score":0.09604716},"labels":[],"label_agreement":null},{"id":"W28721096","doi":"10.2147/cmar.s138643","title":"Partial Perspectives and the Futures of Feminist Archives: Case Studies of Bildwechsel Women+ Video Archive Network and the Canadian Women Artist History Initiative","year":2011,"lang":"en","type":"dissertation","venue":"Cancer Management and Research","topic":"Historical Gender and Feminism Studies","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Futures contract; Women's history; Gender studies; Art; Visual arts; Sociology; Business","score_opus":0.09114842833664913,"score_gpt":0.37422574982519596,"score_spread":0.2830773214885468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W28721096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82982683,0.004036477,0.0006506555,0.027837057,0.000362433,0.00011137025,0.00032224084,0.00002254581,0.13683037],"genre_scores_gemma":[0.9829139,0.001843706,0.0003325828,0.0010628825,0.00008556732,0.000027978384,0.000066924644,0.00002910679,0.013637299],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99622846,0.001772327,0.00005650946,0.00017506976,0.00057923107,0.001188488],"domain_scores_gemma":[0.99570256,0.0020292937,0.00041171728,0.00015954646,0.00029078062,0.001406018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041466868,0.00045079747,0.00033974735,0.0018058806,0.027510522,0.0076987315,0.001979859,0.002370959,0.010876852],"category_scores_gemma":[0.008017309,0.00034888936,0.00039125828,0.0024632073,0.013394482,0.0033200067,0.0063308626,0.0035644255,0.00044144815],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010079387,0.00010808882,0.016466495,0.000104380924,0.000016615666,0.017748086,0.8811326,0.00015049557,0.00027503804,0.04164814,0.015505262,0.026744047],"study_design_scores_gemma":[0.000009184257,0.000023921362,0.0062009674,0.00018694269,0.000009344505,0.004344501,0.87451005,0.00009574999,0.00014564805,0.002313748,0.11213643,0.000023501718],"about_ca_topic_score_codex":0.39246216,"about_ca_topic_score_gemma":0.67749304,"teacher_disagreement_score":0.60753787,"about_ca_system_score_codex":0.025276892,"about_ca_system_score_gemma":0.023999423,"threshold_uncertainty_score":0.7803556},"labels":[],"label_agreement":null},{"id":"W2896397428","doi":"10.2147/cmar.s174143","title":"Long noncoding RNA ROR as a novel biomarker for progress and prognosis outcome in human cancer: a meta-analysis in the Asian population","year":2018,"lang":"en","type":"article","venue":"Cancer Management and Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cochrane Library; Oncology; Internal medicine; Odds ratio; Hazard ratio; Meta-analysis; Population; Confidence interval","score_opus":0.16237116365571946,"score_gpt":0.4652281813274915,"score_spread":0.30285701767177203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896397428","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030165136,0.96623814,0.0016859286,0.00032121767,0.00022484202,0.00013538575,0.0008634168,0.00004403253,0.0003219838],"genre_scores_gemma":[0.7008665,0.29130033,0.003456762,0.0011013733,0.0005059895,0.0007168444,0.0014343043,0.00007033512,0.00054755213],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99379987,0.0027735801,0.0014432505,0.0011369124,0.00055705366,0.0002893533],"domain_scores_gemma":[0.98907465,0.007701554,0.001666621,0.00064569514,0.0007051649,0.00020630092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011469711,0.0024741853,0.0114389295,0.004446372,0.0006537271,0.0026830148,0.0015240903,0.0018329053,0.0023119892],"category_scores_gemma":[0.01641781,0.0010980776,0.045625053,0.0055517307,0.0006323897,0.0013387755,0.0012968453,0.0016270308,0.00025063992],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003305646,0.000029391125,0.028363224,0.05771543,0.9027896,0.00017334045,0.00006603607,0.00079642056,0.00046264846,0.00010137835,0.00031759418,0.005879307],"study_design_scores_gemma":[0.00023286261,0.00017160193,0.009422468,0.0022097204,0.9867062,0.00009724596,0.00002907699,0.00030367216,0.000114957424,0.000156863,0.00053909456,0.000016170992],"about_ca_topic_score_codex":0.0040354244,"about_ca_topic_score_gemma":0.006624781,"teacher_disagreement_score":0.011469711,"about_ca_system_score_codex":0.0012334854,"about_ca_system_score_gemma":0.001679446,"threshold_uncertainty_score":0.060658336},"labels":[],"label_agreement":null},{"id":"W2909817324","doi":"10.2147/cmar.s180802","title":"Comparative study of adjuvant chemotherapeutic efficacy of docetaxel plus cyclophosphamide and doxorubicin plus cyclophosphamide in female breast cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Management and Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Partenariat Canadien Contre Le Cancer","keywords":"Cyclophosphamide; Docetaxel; Doxorubicin; Medicine; Adjuvant; Breast cancer; Oncology; Internal medicine; Pharmacology; Cancer; Chemotherapy","score_opus":0.03608040799540665,"score_gpt":0.3616313771408997,"score_spread":0.3255509691454931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909817324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99620855,0.0032215647,0.000095786876,0.0000147163155,0.000007802163,0.000017864098,0.000093611176,0.0000024522958,0.0003376475],"genre_scores_gemma":[0.9987098,0.00085707195,0.00011246852,0.000026768728,0.00002470212,0.00001367377,0.0001621245,0.0000011848335,0.000092317896],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995765,0.0001357479,0.00007966855,0.00007416979,0.00009917048,0.000034693167],"domain_scores_gemma":[0.9989291,0.0003990917,0.0004061018,0.000047279027,0.0001318717,0.00008667595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008475355,0.00011648978,0.0003164758,0.00037006647,0.00011383882,0.00021294926,0.000112188514,0.00012832643,0.00059533614],"category_scores_gemma":[0.0021695998,0.00006237466,0.00025052094,0.0003915131,0.00015870051,0.00019714572,0.00011999622,0.00013583413,0.0000908684],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015185123,0.0004928842,0.8913337,0.0005545904,0.0006383023,0.0010285474,0.00026830778,0.00039090932,0.008286643,0.00007292691,0.00023637377,0.08151167],"study_design_scores_gemma":[0.00041865092,0.018756496,0.9644734,0.00007123017,0.0007735837,0.00613001,0.00029908362,0.00031154102,0.004100558,0.00004388744,0.004606065,0.000015430542],"about_ca_topic_score_codex":0.00023662555,"about_ca_topic_score_gemma":0.0005386693,"teacher_disagreement_score":0.0008475355,"about_ca_system_score_codex":0.0002827567,"about_ca_system_score_gemma":0.00019688086,"threshold_uncertainty_score":0.0044822097},"labels":[],"label_agreement":null},{"id":"W2924618784","doi":"10.2147/cmar.s189627","title":"<p>A systematic review of international guidelines and recommendations for the genetic screening, diagnosis, genetic counseling, and treatment of <em>BRCA</em>-mutated breast cancer</p>","year":2019,"lang":"en","type":"review","venue":"Cancer Management and Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"European Society for Medical Oncology; Pfizer","keywords":"Medicine; Guideline; Genetic counseling; BRCA mutation; Genetic testing; Breast cancer; Family medicine; MEDLINE; Cancer; Gynecology; Oncology; Internal medicine; Pathology; Genetics","score_opus":0.09430461330640981,"score_gpt":0.4147456970056947,"score_spread":0.32044108369928487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924618784","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012469747,0.9916643,0.00043770592,0.0015887794,0.00030015453,0.0014051556,0.002364789,0.000027832642,0.0009643835],"genre_scores_gemma":[0.011720235,0.9793601,0.0023492894,0.0020846815,0.000109773406,0.0027822992,0.001268574,0.000018455583,0.00030672541],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9834774,0.005586844,0.007116439,0.0009601413,0.0024186594,0.00044048278],"domain_scores_gemma":[0.95898795,0.023696823,0.010308139,0.0006118303,0.005781909,0.0006133937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014965526,0.0018157717,0.007082033,0.015714377,0.0010714644,0.0026973484,0.0030038042,0.0023881441,0.005608616],"category_scores_gemma":[0.06786388,0.0013325504,0.0066241724,0.01618375,0.0012516177,0.003190731,0.0019477523,0.0016099879,0.00062032003],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010216885,0.000011453695,0.0007096904,0.9600752,0.003383092,0.00006769197,0.00032038442,0.0000770243,0.000119908254,0.00028482347,0.00533789,0.029510716],"study_design_scores_gemma":[0.00015897282,0.00006466511,0.0019312664,0.9541577,0.021412766,0.0001347811,0.00027380162,0.000046158086,0.00009693765,0.00023687804,0.021461079,0.000025019677],"about_ca_topic_score_codex":0.018167531,"about_ca_topic_score_gemma":0.060670435,"teacher_disagreement_score":0.018167531,"about_ca_system_score_codex":0.0062089753,"about_ca_system_score_gemma":0.031337105,"threshold_uncertainty_score":0.07914621},"labels":[],"label_agreement":null},{"id":"W2938854690","doi":"10.2147/cmar.s197644","title":"<p>The crucial role of primary care providers in the long-term follow-up of adult survivors of childhood cancer</p>","year":2019,"lang":"en","type":"article","venue":"Cancer Management and Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Medicine; Psychosocial; Childhood cancer; Cancer; Systematic review; Cochrane Library; Quality of life (healthcare); MEDLINE; Family medicine; Survivorship curve; Health care; Randomized controlled trial; Pediatrics; Psychiatry; Nursing; Internal medicine","score_opus":0.02631559727138589,"score_gpt":0.3277269282594806,"score_spread":0.3014113309880947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2938854690","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044277348,0.9706998,0.000496206,0.017240942,0.0011249069,0.00027791483,0.0007353125,0.000016602437,0.0049806526],"genre_scores_gemma":[0.07598754,0.9076428,0.0051470003,0.008319538,0.0011179245,0.0005199136,0.0004983805,0.00001598542,0.0007508561],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99469286,0.0028688554,0.0010057932,0.00031404477,0.0008904857,0.00022793966],"domain_scores_gemma":[0.95559394,0.033698052,0.0058769714,0.000721362,0.0034442903,0.00066531514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0088979425,0.00028419262,0.001052911,0.0020993953,0.000737359,0.0023241795,0.0006656576,0.0017246421,0.005124162],"category_scores_gemma":[0.042882502,0.0002844203,0.0014618344,0.0033589513,0.00077639916,0.0024913324,0.0011591298,0.0014297325,0.00044184978],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039773365,0.00007062009,0.013435025,0.35848328,0.002327633,0.00061657466,0.0020070209,0.00019531652,0.00062047073,0.0049552787,0.054902505,0.5619886],"study_design_scores_gemma":[0.00035875046,0.0005473887,0.051098973,0.66456985,0.007264756,0.0019977745,0.0049435543,0.00027009184,0.0010738124,0.0057960185,0.261992,0.00008702526],"about_ca_topic_score_codex":0.0099223275,"about_ca_topic_score_gemma":0.024772117,"teacher_disagreement_score":0.0099223275,"about_ca_system_score_codex":0.002406944,"about_ca_system_score_gemma":0.012394035,"threshold_uncertainty_score":0.04705739},"labels":[],"label_agreement":null},{"id":"W2946988085","doi":"10.2147/cmar.s199432","title":"<p>Predictors of postoperative complications after robot-assisted radical cystectomy with extracorporeal urinary diversion</p>","year":2019,"lang":"en","type":"article","venue":"Cancer Management and Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Korea Health Industry Development Institute; National Research Foundation; Société Internationale D'Urologie","keywords":"Medicine; Cystectomy; Urinary diversion; Perioperative; Extracorporeal; Urinary system; Surgery; Odds ratio; Logistic regression; Anastomosis; Ileus; Urology; Bladder cancer; Internal medicine; Cancer","score_opus":0.03365447327549187,"score_gpt":0.32413062899865863,"score_spread":0.29047615572316676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946988085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990056,0.0005334633,0.00014486315,0.000036088673,0.00000796139,0.000004544161,0.00007177089,0.0000046922232,0.0001910196],"genre_scores_gemma":[0.9996531,0.00009548976,0.000074317446,0.000007939678,0.000009535439,0.000003640402,0.00010248953,0.0000012818365,0.000052198324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997738,0.00004670199,0.000050936495,0.000030047491,0.00005592007,0.000042671123],"domain_scores_gemma":[0.997881,0.000433727,0.0012370322,0.0000516454,0.00015829255,0.00023829952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003554764,0.00022186569,0.0001629872,0.00035837237,0.00022752793,0.00038462525,0.00020903052,0.00022596552,0.00093100686],"category_scores_gemma":[0.0029694312,0.000114549766,0.00034205106,0.0004887408,0.00022765031,0.00032334338,0.00023628579,0.00043101824,0.00012056315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000615915,0.00001160183,0.9980819,0.0000099958725,0.000016243122,0.00014858147,0.0000071827417,0.000064610285,0.000065522065,0.0000043900773,0.00005471671,0.0014737243],"study_design_scores_gemma":[0.0000060935154,0.00010583189,0.9971566,0.000012310719,0.00003726414,0.0017334279,0.000046123238,0.0005117772,0.00021099596,0.000016351958,0.00015880931,0.000004323208],"about_ca_topic_score_codex":0.0009608741,"about_ca_topic_score_gemma":0.0012651422,"teacher_disagreement_score":0.0009608741,"about_ca_system_score_codex":0.00019812261,"about_ca_system_score_gemma":0.0004208413,"threshold_uncertainty_score":0.003114462},"labels":[],"label_agreement":null},{"id":"W2980023091","doi":"10.2147/cmar.s212899","title":"<p>Time Trends And Age-Period-Cohort Effects On The Incidence Of Gastric Cancer In Changle From 2003 To 2012</p>","year":2019,"lang":"en","type":"article","venue":"Cancer Management and Research","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Incidence (geometry); Medicine; Cohort; Cancer; Cohort effect; Demography; Cohort study; Population; Internal medicine; Environmental health","score_opus":0.024709988217616583,"score_gpt":0.32583875514884775,"score_spread":0.30112876693123114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980023091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99627507,0.00074858556,0.0002415852,0.0002625686,0.000027669616,0.000012206143,0.0018937148,0.000018287072,0.0005203566],"genre_scores_gemma":[0.99805486,0.00014566466,0.00011160213,0.00004522497,0.000013123679,0.000011265976,0.0012646052,0.0000067295005,0.00034693303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994099,0.00012653727,0.000044144344,0.00018037975,0.00007718937,0.0001617495],"domain_scores_gemma":[0.9972464,0.0003854823,0.0009800659,0.00036823814,0.00064850936,0.00037131796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015891425,0.00028750955,0.00021154038,0.0011354581,0.00038486015,0.00046156056,0.00045048087,0.0002959461,0.0014588645],"category_scores_gemma":[0.0026612708,0.00022645401,0.0009388282,0.0015650368,0.0002416711,0.00044690992,0.0005411026,0.00050153746,0.00015940041],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012682255,0.000012039957,0.9972957,0.0000114333125,0.00009928221,0.00004559533,0.000108200176,0.000085613385,0.00013593984,0.000031253763,0.00025431832,0.0017939194],"study_design_scores_gemma":[0.0000021071085,0.0000290673,0.9991959,0.000006364173,0.000049531984,0.000019610869,0.000070871894,0.00032003547,0.00005151017,0.000010802969,0.00024143727,0.0000028401391],"about_ca_topic_score_codex":0.07685003,"about_ca_topic_score_gemma":0.10178478,"teacher_disagreement_score":0.07685003,"about_ca_system_score_codex":0.0011388573,"about_ca_system_score_gemma":0.0015043282,"threshold_uncertainty_score":0.15280545},"labels":[],"label_agreement":null},{"id":"W2982561040","doi":"10.2147/cmar.s213051","title":"<p>Population-Based Analysis Of The Use Of Radium-223 For Bone-Metastatic Castration-Resistant Prostate Cancer In Ontario, And Of Factors Associated With Treatment Completion And Outcome</p>","year":2019,"lang":"en","type":"article","venue":"Cancer Management and Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Regional Municipality of Durham; Princess Margaret Cancer Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"Sanofi Genzyme; Bayer Canada; Astellas Pharma; Endocyte; Bavarian Nordic; Sanofi; Exelixis; Genentech; AstraZeneca; Amgen","keywords":"Medicine; Prostate cancer; Discontinuation; Enzalutamide; Radium-223; Proportional hazards model; Internal medicine; Cohort; Hazard ratio; Docetaxel; Prostate-specific antigen; Abiraterone acetate; Oncology; Population; Cancer; Androgen deprivation therapy; Bone metastasis; Confidence interval","score_opus":0.1496487276642577,"score_gpt":0.3775254693243324,"score_spread":0.22787674166007468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982561040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983076,0.00010132696,0.000036872967,0.000035342724,0.0000014667451,0.00002004001,0.001222866,0.0000035139378,0.00027115335],"genre_scores_gemma":[0.999111,0.0000751231,0.000034375433,0.000015251241,0.0000026620828,0.000012323242,0.0005922099,0.0000014436081,0.00015565334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99945503,0.00005865599,0.000054041997,0.00013454996,0.0001672256,0.0001304378],"domain_scores_gemma":[0.9977701,0.00013774753,0.0012934896,0.00012021522,0.00032257006,0.00035584878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048426987,0.00026517693,0.0002627253,0.00087924884,0.00082501303,0.00061445293,0.00076195947,0.00033041756,0.0013781722],"category_scores_gemma":[0.0015941338,0.00040483198,0.00050134177,0.0023152505,0.00068469613,0.00029562772,0.0005896324,0.00034513604,0.00019631849],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004826445,0.000009767494,0.99911815,0.000010655123,0.000025102054,0.0000317019,0.00013039706,0.000032235792,0.00010437049,0.0000054738034,0.00010038111,0.00038346506],"study_design_scores_gemma":[0.000004192545,0.00002393635,0.9995896,0.0000030966264,0.000009654958,0.000034252367,0.0001551128,0.000061851366,0.000014819673,0.0000021658213,0.000099369645,0.0000018926678],"about_ca_topic_score_codex":0.7762674,"about_ca_topic_score_gemma":0.805231,"teacher_disagreement_score":0.22373259,"about_ca_system_score_codex":0.0064080614,"about_ca_system_score_gemma":0.0057927663,"threshold_uncertainty_score":0.45010036},"labels":[],"label_agreement":null},{"id":"W2989815114","doi":"10.2147/cmar.s226174","title":"<p>Serum Adipokines as Predictors for the Outcome of Prostate Biopsies at Early Stage Prostate Cancer Diagnosis</p>","year":2019,"lang":"en","type":"article","venue":"Cancer Management and Research","topic":"Adipokines, Inflammation, and Metabolic Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Prostate Cancer Canada; Canadian Urological Association Scholarship Fund; Canadian Urological Association","keywords":"Adipokine; Medicine; Prostate cancer; Resistin; Prostate biopsy; Internal medicine; Biopsy; Oncology; Prostate; Gastroenterology; Cancer; Leptin; Obesity","score_opus":0.036535159516987055,"score_gpt":0.34869279467646125,"score_spread":0.3121576351594742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989815114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990208,0.00037996555,0.00009524079,0.000049243885,0.000007873636,0.0000062218737,0.00018937011,0.0000047963963,0.00024636317],"genre_scores_gemma":[0.9995648,0.00004716339,0.000051175506,0.000014412335,0.000012307847,0.000004465972,0.00019347706,0.000001127397,0.000111097215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979144,0.00008135783,0.000015179212,0.000039623803,0.00004364583,0.000028785365],"domain_scores_gemma":[0.99849355,0.0003648135,0.0006629115,0.00005618041,0.00012217542,0.0003004064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006467966,0.00023362071,0.0002383521,0.00036713094,0.00015127586,0.0003830766,0.00023189858,0.00032389132,0.0010718226],"category_scores_gemma":[0.0021742056,0.00010105185,0.00019749512,0.00034864663,0.0002586707,0.00023195696,0.00019520843,0.00049142924,0.00020297013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008126682,0.000042234555,0.9966036,0.000013825789,0.000035520483,0.00004117424,0.000009044935,0.0000740391,0.00028237296,0.0000065451563,0.00009555346,0.0019834766],"study_design_scores_gemma":[0.00003458863,0.00035379242,0.9984806,0.0000073914825,0.000053843843,0.0002098834,0.000021490892,0.00044628922,0.00023910945,0.000026687676,0.00012298397,0.0000033325875],"about_ca_topic_score_codex":0.001113993,"about_ca_topic_score_gemma":0.0012947083,"teacher_disagreement_score":0.001113993,"about_ca_system_score_codex":0.00017460877,"about_ca_system_score_gemma":0.00022474119,"threshold_uncertainty_score":0.003585577},"labels":[],"label_agreement":null},{"id":"W2996643479","doi":"10.2147/cmar.s232051","title":"<p>The Personalized Shoulder Reconstruction Assisted by 3D Printing Technology After Resection of the Proximal Humerus Tumours</p>","year":2019,"lang":"en","type":"article","venue":"Cancer Management and Research","topic":"Shoulder Injury and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Prosthesis; Range of motion; Arthroplasty; Surgery; Shoulder Prosthesis; Humerus; Implant; Proximal humerus; Complication","score_opus":0.033944449674790766,"score_gpt":0.3485203004115429,"score_spread":0.31457585073675215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996643479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857022,0.0016405603,0.010606629,0.00006233296,0.000031898562,0.000043887925,0.00009037826,0.00014082146,0.0016813072],"genre_scores_gemma":[0.99258864,0.0004875707,0.005560533,0.00005278147,0.000018196397,0.000023099587,0.0001097739,0.000019979494,0.0011394168],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983776,0.000024965848,0.000021045862,0.000030213865,0.000055334087,0.00003069215],"domain_scores_gemma":[0.99978334,0.000040844323,0.000094013594,0.00004985611,0.000012783269,0.000019190398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026448083,0.00032141048,0.0002389166,0.0003704369,0.00018799306,0.00028916966,0.00023619324,0.00030943975,0.0013626076],"category_scores_gemma":[0.00045110311,0.00013142847,0.0005835457,0.00025897153,0.00035548166,0.00025161417,0.00029080917,0.0002722278,0.0005780939],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012900283,0.00046529374,0.15146185,0.00079060264,0.00029278116,0.049023114,0.00058528176,0.0053160847,0.28565398,0.00043241354,0.0017114744,0.50297713],"study_design_scores_gemma":[0.00013274692,0.0049309144,0.3555508,0.00010460864,0.00027874229,0.45156348,0.0002436126,0.0098919235,0.16612016,0.00038349922,0.010718222,0.00008116956],"about_ca_topic_score_codex":0.0003542862,"about_ca_topic_score_gemma":0.0008510031,"teacher_disagreement_score":0.0013626076,"about_ca_system_score_codex":0.00018178155,"about_ca_system_score_gemma":0.00025653027,"threshold_uncertainty_score":0.004558444},"labels":[],"label_agreement":null},{"id":"W2998979114","doi":"10.2147/cmar.s233215","title":"<p>Predictors of Survival Among Colorectal Cancer Patients in a Low Incidence Area</p>","year":2020,"lang":"en","type":"article","venue":"Cancer Management and Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal General Hospital","funders":"King Saud University","keywords":"Medicine; Colorectal cancer; Internal medicine; Cancer registry; Oncology; Cancer; Proportional hazards model; Regimen; Family history; Malignancy; Incidence (geometry)","score_opus":0.04047344810942759,"score_gpt":0.33279692061738786,"score_spread":0.29232347250796026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998979114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99951494,0.00008471792,0.000018964914,0.00009779825,0.0000031318875,0.0000025641607,0.00012856539,0.000001506092,0.00014781031],"genre_scores_gemma":[0.99969375,0.000048490976,0.000026419408,0.000018275703,0.000005498734,0.000002906211,0.00013859727,6.2871845e-7,0.00006541586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998411,0.000035855348,0.000019056764,0.000024757877,0.000025817608,0.00005327782],"domain_scores_gemma":[0.9987361,0.00016152102,0.0006349002,0.000027325541,0.0001260759,0.0003140198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028698074,0.00015214861,0.00014436485,0.0004527455,0.0004033306,0.0005368742,0.00021735803,0.00024264428,0.0021528117],"category_scores_gemma":[0.0016550526,0.00011263927,0.00018090178,0.0006954674,0.00020832062,0.00031608684,0.00034039235,0.00045444546,0.00028913908],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019620737,0.000008557878,0.9994299,0.000003665568,0.0000032918535,0.000035886635,0.000022864686,0.000012407305,0.000028020437,0.000003989758,0.00007028447,0.0003614658],"study_design_scores_gemma":[0.0000041350704,0.000059397757,0.9990816,0.0000060295138,0.00001070517,0.00017882153,0.00030368796,0.00017389742,0.00003117506,0.000014330785,0.00013443135,0.000001782547],"about_ca_topic_score_codex":0.008539343,"about_ca_topic_score_gemma":0.009720986,"teacher_disagreement_score":0.008539343,"about_ca_system_score_codex":0.00038727466,"about_ca_system_score_gemma":0.0005383716,"threshold_uncertainty_score":0.016979277},"labels":[],"label_agreement":null},{"id":"W3005513992","doi":"10.2147/cmar.s237770","title":"<p>The Cost of Bottling It Up: Emotion Suppression as a Mediator in the Relationship Between Anger and Depression Among Men with Prostate Cancer</p>","year":2020,"lang":"en","type":"article","venue":"Cancer Management and Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Health and Medical Research Council; Medical Research Council; Canadian Institutes of Health Research","keywords":"Anger; Prostate cancer; Clinical psychology; Depression (economics); Psychology; Anxiety; Distress; Mood; Mediation; Feeling; Suicidal ideation; Cancer; Medicine; Psychiatry; Oncology; Internal medicine; Poison control; Suicide prevention","score_opus":0.07524738102985677,"score_gpt":0.3653762734647695,"score_spread":0.2901288924349127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005513992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970764,0.00058811705,0.0001495941,0.0008991539,0.000014983975,0.0000140085795,0.000107881846,0.000005323897,0.001144653],"genre_scores_gemma":[0.99919206,0.00017321152,0.00015466638,0.000074776086,0.000015677208,0.000012409974,0.000059009973,0.0000017193062,0.0003164062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99970955,0.00018617099,0.0000109251405,0.000023641871,0.00004204803,0.000027630816],"domain_scores_gemma":[0.9988097,0.00057246664,0.00033293775,0.00004433188,0.0000684519,0.00017210003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010063502,0.00017420066,0.00019112109,0.00020441937,0.00032947166,0.00069250603,0.00026969428,0.00022663892,0.0045305905],"category_scores_gemma":[0.0025108508,0.0002059265,0.00043668164,0.00021568747,0.0002885715,0.00055550615,0.00043833547,0.0006012093,0.00024917218],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013449487,0.00020563234,0.9668581,0.0001252138,0.00016714157,0.00024954943,0.0010562509,0.00016775863,0.0009643077,0.00025497228,0.0008541117,0.02775207],"study_design_scores_gemma":[0.000026537127,0.0002712097,0.9967777,0.000039851042,0.00011963178,0.00020828604,0.00078674394,0.00083395146,0.0003277997,0.00022459513,0.00037625435,0.000007475068],"about_ca_topic_score_codex":0.003264706,"about_ca_topic_score_gemma":0.005433938,"teacher_disagreement_score":0.0045305905,"about_ca_system_score_codex":0.0003051365,"about_ca_system_score_gemma":0.00038494638,"threshold_uncertainty_score":0.015156269},"labels":[],"label_agreement":null},{"id":"W3005584727","doi":"10.2147/cmar.s235777","title":"<p>Cancer Patient-Reported Preferences and Knowledge for Liquid Biopsies and Blood Biomarkers at a Comprehensive Cancer Center</p>","year":2020,"lang":"en","type":"article","venue":"Cancer Management and Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Public Health Ontario; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Cancer; Center (category theory); Liquid biopsy; Internal medicine; Oncology; Chemistry","score_opus":0.05742300231260812,"score_gpt":0.33504692712722645,"score_spread":0.27762392481461834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005584727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991978,0.000043751486,0.000024854282,0.00019464055,9.630555e-7,0.000007472543,0.000091855625,0.0000023670987,0.00043636185],"genre_scores_gemma":[0.99953616,0.000035483277,0.00007962917,0.00010036231,0.0000018075211,0.000011528701,0.00006276268,8.363318e-7,0.00017146871],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995394,0.00019843302,0.000035853893,0.000057748734,0.00007581964,0.00009286684],"domain_scores_gemma":[0.9965,0.001243061,0.0011215169,0.000056759898,0.00018114074,0.00089752924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009311563,0.00012491323,0.00015301793,0.00024312643,0.00044468654,0.00057881535,0.00021416426,0.00041301365,0.0064868894],"category_scores_gemma":[0.0040833163,0.00013771805,0.00022110943,0.00027795092,0.00025983664,0.00044551303,0.00031128523,0.00042412608,0.00032793396],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006844132,0.00030850773,0.9794988,0.000058272843,0.000047857517,0.0005017405,0.0030624005,0.00045296588,0.0009195568,0.00004305942,0.0029389176,0.011483504],"study_design_scores_gemma":[0.000062721374,0.0013839848,0.98912394,0.00005667739,0.00003410557,0.0006146593,0.005404513,0.0017495841,0.00043392763,0.000058252706,0.0010495977,0.000028109378],"about_ca_topic_score_codex":0.012100773,"about_ca_topic_score_gemma":0.016189743,"teacher_disagreement_score":0.012100773,"about_ca_system_score_codex":0.0010522477,"about_ca_system_score_gemma":0.0006804535,"threshold_uncertainty_score":0.024060726},"labels":[],"label_agreement":null},{"id":"W3093731804","doi":"10.2147/cmar.s249540","title":"<p>Further Understanding of High-Grade Serous Ovarian Carcinogenesis: Potential Therapeutic Targets</p>","year":2020,"lang":"en","type":"review","venue":"Cancer Management and Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Essar Steel Algoma (Canada); Sault Area Hospital","funders":"","keywords":"Ovarian carcinoma; Ovarian cancer; Cancer research; Medicine; Serous fluid; Carcinogenesis; Targeted therapy; Immune system; Kinome; Bevacizumab; Cancer; Chemotherapy; Immunology; Kinase; Biology; Internal medicine","score_opus":0.18286264737513697,"score_gpt":0.40648633523991506,"score_spread":0.2236236878647781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093731804","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002475759,0.99524176,0.0002613128,0.00077995023,0.0003683583,0.000010007518,0.00003615598,0.000018228877,0.0030366704],"genre_scores_gemma":[0.0015021551,0.9955792,0.00033928204,0.00049967517,0.00023494588,0.000009503528,0.00007473478,0.000003006715,0.0017574832],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998876,0.000021275679,0.000010701165,0.00001713682,0.000047890735,0.000015303936],"domain_scores_gemma":[0.999814,0.00007469758,0.00002627759,0.0000065563036,0.000058097296,0.000020574711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041292742,0.00046158562,0.0006253693,0.0011858863,0.00018209658,0.0007465784,0.00048024708,0.0007382808,0.0048953188],"category_scores_gemma":[0.00044349546,0.00012944099,0.00040477136,0.0011165551,0.00028381002,0.0009153879,0.00043040366,0.0017132831,0.0021641664],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005888383,0.000070348004,0.00014742685,0.010923487,0.00005459134,0.00020249127,0.000047631354,0.00030754125,0.0028016854,0.004979912,0.04264038,0.9377656],"study_design_scores_gemma":[0.000016396587,0.00010271496,0.00056654634,0.002027108,0.0000567188,0.0008812925,0.000042368305,0.000113996284,0.00059109565,0.0017540756,0.99383837,0.0000093454155],"about_ca_topic_score_codex":0.00074246083,"about_ca_topic_score_gemma":0.0015668507,"teacher_disagreement_score":0.0048953188,"about_ca_system_score_codex":0.0004388897,"about_ca_system_score_gemma":0.000765992,"threshold_uncertainty_score":0.016376495},"labels":[],"label_agreement":null},{"id":"W3112377387","doi":"10.2147/cmar.s267824","title":"<p>Relationship of Adherence to Cervical Cancer Treatment Guideline Towards Patients’ Five-year Survival: Systematic Review of Follow-up Trials</p>","year":2020,"lang":"en","type":"review","venue":"Cancer Management and Research","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Universitas Indonesia","keywords":"Medicine; Guideline; Cervical cancer; Cancer; Stage (stratigraphy); Clinical trial; Internal medicine; Systematic review; Gynecology; MEDLINE; Oncology; Family medicine; Pathology","score_opus":0.3133293873039991,"score_gpt":0.500655726870806,"score_spread":0.18732633956680683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112377387","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006741734,0.9889227,0.0004064078,0.0005904037,0.00023613183,0.0015839442,0.0010830278,0.000024707366,0.00041092598],"genre_scores_gemma":[0.19831279,0.7877871,0.0031912082,0.0021181123,0.0002711372,0.006515806,0.0013063517,0.00002955114,0.0004680077],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98036754,0.008293268,0.0071422243,0.0013606141,0.0024190838,0.00041724165],"domain_scores_gemma":[0.93757695,0.04288168,0.013349089,0.0013429008,0.004308551,0.00054084364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019582119,0.0013301654,0.009927477,0.0047126445,0.00075790443,0.0029135812,0.0017438857,0.0022745284,0.0044422136],"category_scores_gemma":[0.092310384,0.000995321,0.015207948,0.006824718,0.0010528543,0.0028158163,0.0014455024,0.0018836699,0.00026912228],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008747802,0.000025283325,0.0029306943,0.9153868,0.06665136,0.000054192053,0.00017913309,0.00009002139,0.00008599334,0.00014512175,0.00085500616,0.012721606],"study_design_scores_gemma":[0.0017399887,0.0006720305,0.014676708,0.5292384,0.44617775,0.00019258806,0.0003146309,0.00024198808,0.0002532765,0.00042111523,0.0060026064,0.00006895687],"about_ca_topic_score_codex":0.008686976,"about_ca_topic_score_gemma":0.021329585,"teacher_disagreement_score":0.019582119,"about_ca_system_score_codex":0.0036777959,"about_ca_system_score_gemma":0.008782268,"threshold_uncertainty_score":0.1035614},"labels":[],"label_agreement":null},{"id":"W3120590657","doi":"10.2147/cmar.s264526","title":"Information Needs of Breast Cancer Patients Attending Care at Tikur Anbessa Specialized Hospital: A Descriptive Study","year":2021,"lang":"en","type":"article","venue":"Cancer Management and Research","topic":"Health Literacy and Information Accessibility","field":"Health Professions","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Addis Ababa University","keywords":"Breast cancer; Information needs; Medicine; Residence; Family medicine; Descriptive statistics; Health care; Needs assessment; Cancer; Statistical significance; Internal medicine; Demography","score_opus":0.07851319219175304,"score_gpt":0.4778208369080851,"score_spread":0.39930764471633207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120590657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995011,0.000113881935,0.000013581723,0.000051990784,0.0000011209678,0.0000142456365,0.00008061995,6.2480456e-7,0.00022284074],"genre_scores_gemma":[0.9994,0.0002058885,0.00006964131,0.000051022445,0.0000027632366,0.000024774607,0.00009815213,4.574377e-7,0.00014738597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967265,0.000069847905,0.00006169514,0.000026921578,0.00007558657,0.00009335566],"domain_scores_gemma":[0.99901533,0.0002959843,0.0003442921,0.000016072301,0.00012750599,0.00020070911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004667366,0.00010731395,0.0002871534,0.0010970796,0.0006075606,0.0004872123,0.0002056465,0.00025940692,0.0013098564],"category_scores_gemma":[0.0015817591,0.00018860566,0.00027182218,0.0009023555,0.00022928143,0.0004994698,0.0004354894,0.0003277155,0.00010892704],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010471705,0.00025137523,0.9843593,0.00014695541,0.000022033526,0.00068197673,0.008197183,0.000033756252,0.00036221475,0.000048189166,0.00029796307,0.00549424],"study_design_scores_gemma":[0.000013984758,0.0005721665,0.9431854,0.00010886704,0.00003308808,0.0019885828,0.051970813,0.00020115855,0.00020285479,0.000045829205,0.0016570822,0.000020124593],"about_ca_topic_score_codex":0.0042562396,"about_ca_topic_score_gemma":0.0053368253,"teacher_disagreement_score":0.0042562396,"about_ca_system_score_codex":0.00066576066,"about_ca_system_score_gemma":0.0007064608,"threshold_uncertainty_score":0.0084629655},"labels":[],"label_agreement":null},{"id":"W3144575100","doi":"10.2147/cmar.s284439","title":"The Participatory Approach: A Specific French Organizational Model at the Department Level to Serve the Quality of Work Life of Healthcare Providers and the Quality of Care in Pediatric Oncology","year":2021,"lang":"en","type":"article","venue":"Cancer Management and Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"HEC Montréal","funders":"Fondation de France; Société Française de lutte contre les Cancers et les leucémies de l'Enfant et de l'Adolescent","keywords":"Health care; Quality (philosophy); Medicine; Citizen journalism; Nursing; Job satisfaction; Perception; Family medicine; Work (physics); Pediatric oncology; Psychology; Internal medicine; Cancer","score_opus":0.295458867360331,"score_gpt":0.4629809697901707,"score_spread":0.16752210242983973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3144575100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9187193,0.0038200554,0.025235893,0.017226001,0.00026176265,0.00048299372,0.00012880065,0.00007160486,0.034053702],"genre_scores_gemma":[0.99122214,0.0005013876,0.0060755764,0.0005777962,0.00004469364,0.00016136032,0.00003859316,0.000006757912,0.0013716512],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9851273,0.011624839,0.00021281524,0.00064205006,0.0011560891,0.0012370452],"domain_scores_gemma":[0.9913175,0.002971691,0.0018549305,0.00055961456,0.0010075523,0.0022885997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068890015,0.00032546438,0.00015384365,0.00091551174,0.0026530218,0.00267557,0.00087153004,0.0008682366,0.0020647538],"category_scores_gemma":[0.008670689,0.00017628768,0.00059114577,0.0008972376,0.0026904512,0.0012518073,0.0028849866,0.001112317,0.00017660145],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025189537,0.0010620195,0.513594,0.00086546066,0.00025802708,0.0019658057,0.12663953,0.00309272,0.0036758147,0.06311407,0.009041757,0.27643895],"study_design_scores_gemma":[0.00013168507,0.0013112747,0.69699925,0.0013223622,0.00017538789,0.0029689025,0.13174565,0.0048968303,0.0013598007,0.019054724,0.13988064,0.00015352997],"about_ca_topic_score_codex":0.01591931,"about_ca_topic_score_gemma":0.022901777,"teacher_disagreement_score":0.01591931,"about_ca_system_score_codex":0.0068908385,"about_ca_system_score_gemma":0.0104543315,"threshold_uncertainty_score":0.049996734},"labels":[],"label_agreement":null},{"id":"W3161673538","doi":"10.2147/cmar.s307713","title":"A Community Hospital-Based Study: A Prespecified Neutrophil Count with Adjuvant mFOLFOX6 Associated with Increased Delays, Increased G-CSF Use, and Reduced Dose Intensity","year":2021,"lang":"en","type":"article","venue":"Cancer Management and Research","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Augmentium Pharma Consulting (Canada); The Scarborough Hospital","funders":"","keywords":"Medicine; Chemotherapy; Granulocyte colony-stimulating factor; Colorectal cancer; Internal medicine; Absolute neutrophil count; Adjuvant; Adjuvant chemotherapy; Gastroenterology; Cancer; Surgery; Neutropenia","score_opus":0.08231561687394603,"score_gpt":0.34198405025717726,"score_spread":0.2596684333832312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161673538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99957496,0.00006207347,0.000016546635,0.00005317427,0.0000047695453,0.0000110900855,0.00006216488,8.294016e-7,0.0002143994],"genre_scores_gemma":[0.9997242,0.000030371948,0.000018358993,0.000054973993,0.000008575294,0.0000056980457,0.000072245966,0.0000014900631,0.00008418744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983398,0.00040861793,0.00012079506,0.0003684932,0.0003307817,0.00043153384],"domain_scores_gemma":[0.99421424,0.0007694283,0.0027162395,0.00023567735,0.0006650295,0.0013993823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007069144,0.00039332933,0.0003043732,0.0006303071,0.0013032014,0.0012522325,0.00062253367,0.00086233945,0.003372523],"category_scores_gemma":[0.0052772523,0.0004392961,0.0005131082,0.0017221492,0.0006803021,0.0006115384,0.00066684844,0.0011760198,0.00022460088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009561174,0.00009268722,0.9990809,0.0000063826105,0.000025304453,0.00011792014,0.00014290822,0.000009615155,0.00005981404,0.000008489424,0.00007179349,0.00028864288],"study_design_scores_gemma":[0.000031026288,0.00028959545,0.9976554,0.000013457611,0.000031359577,0.00034397183,0.00125794,0.00014380546,0.000031748063,0.000012762193,0.00018135786,0.0000074842405],"about_ca_topic_score_codex":0.13710527,"about_ca_topic_score_gemma":0.1846087,"teacher_disagreement_score":0.13710527,"about_ca_system_score_codex":0.0024852892,"about_ca_system_score_gemma":0.0033667006,"threshold_uncertainty_score":0.27261448},"labels":[],"label_agreement":null},{"id":"W3195711664","doi":"10.2147/cmar.s324203","title":"Transcriptome Signature of Immune Cells Post Reovirus Treatment in KRAS Mutated Colorectal Cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Management and Research","topic":"Viral gastroenteritis research and epidemiology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Oncolytics Biotech; Yeshiva University","keywords":"KRAS; Colorectal cancer; Peripheral blood mononuclear cell; Transcriptome; Cancer research; Immune system; Gene; Oncolytic virus; Biology; Cancer; Medicine; Immunology; Gene expression; Internal medicine; Genetics","score_opus":0.04452024175985621,"score_gpt":0.3903088371135194,"score_spread":0.3457885953536632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195711664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935441,0.0018056236,0.00095930614,0.00006729132,0.000035382953,0.000032564298,0.0022888696,0.00004687269,0.0012199838],"genre_scores_gemma":[0.9926179,0.0009288152,0.0010432324,0.00010720092,0.000015279298,0.0001184232,0.0028149846,0.000018320145,0.0023357784],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987996,0.000014931868,0.0000060358625,0.00003409617,0.000030035122,0.000034878318],"domain_scores_gemma":[0.99992955,0.000010054233,0.000019373407,0.0000052874875,0.000016351474,0.000019331068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000820089,0.00014590807,0.00035494255,0.00031788863,0.00018922059,0.00025384303,0.00006215526,0.00019347329,0.0015383579],"category_scores_gemma":[0.00013018913,0.000086231325,0.0002563606,0.0003170487,0.00013008565,0.00013327062,0.00016614569,0.0003621624,0.00030180984],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008567573,0.000043839034,0.0067920145,0.00012283768,0.00002251786,0.000088261935,0.000110268615,0.00013131638,0.9872321,0.000044071556,0.00021019872,0.004345936],"study_design_scores_gemma":[0.00006145326,0.002111977,0.6467946,0.0000519279,0.00016814662,0.00088801235,0.0010345766,0.003545717,0.335811,0.00025881035,0.009238117,0.0000356553],"about_ca_topic_score_codex":0.0003778194,"about_ca_topic_score_gemma":0.0005580407,"teacher_disagreement_score":0.0015383579,"about_ca_system_score_codex":0.00018171276,"about_ca_system_score_gemma":0.00015014318,"threshold_uncertainty_score":0.0051463246},"labels":[],"label_agreement":null},{"id":"W3216453704","doi":"10.2147/cmar.s335386","title":"Pathum Raksa Project: Addressing Disparity in Breast Cancer Care Through National Innovation in Thailand","year":2021,"lang":"en","type":"article","venue":"Cancer Management and Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Royal Columbian Hospital","funders":"Khon Kaen University; Prince of Songkla University; Chiang Mai University","keywords":"Breast cancer; Medicine; Biomarker; Triple-negative breast cancer; Cancer; Oncology; Internal medicine","score_opus":0.08337336692145347,"score_gpt":0.4130384032597281,"score_spread":0.32966503633827465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216453704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.817455,0.014685604,0.009346666,0.089604504,0.0013395305,0.0034028816,0.0051234383,0.0006494489,0.058392935],"genre_scores_gemma":[0.95944524,0.007825821,0.013284179,0.005920194,0.00025345478,0.0028318225,0.0021555873,0.000074696145,0.008208975],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99382895,0.0034315076,0.00029980508,0.00030266552,0.0009033467,0.0012337103],"domain_scores_gemma":[0.98456675,0.0030451159,0.0017885945,0.0005535093,0.0019940916,0.008051927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0089537995,0.0004982041,0.00030601837,0.0010239151,0.00212041,0.0040267347,0.0013450942,0.00087234174,0.007237668],"category_scores_gemma":[0.010281652,0.00026401095,0.00066382356,0.001625405,0.0011302211,0.0020634101,0.010414726,0.0019959584,0.00076122064],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010838178,0.0017129928,0.4031622,0.0051765013,0.00029922696,0.002321791,0.011717846,0.0028210739,0.0036115132,0.0156231625,0.056252617,0.49621725],"study_design_scores_gemma":[0.0008237716,0.005913295,0.66843504,0.006451614,0.0005634482,0.0039060214,0.046859052,0.011624091,0.0064431992,0.012807818,0.23587835,0.00029434482],"about_ca_topic_score_codex":0.014454745,"about_ca_topic_score_gemma":0.010806704,"teacher_disagreement_score":0.014454745,"about_ca_system_score_codex":0.004833234,"about_ca_system_score_gemma":0.055953536,"threshold_uncertainty_score":0.04735273},"labels":[],"label_agreement":null},{"id":"W4207032141","doi":"10.2147/cmar.s273544","title":"Managing 5FU Cardiotoxicity in Colorectal Cancer Treatment","year":2022,"lang":"en","type":"article","venue":"Cancer Management and Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cardiotoxicity; Colorectal cancer; Chemotherapy; Fluorouracil; Cancer","score_opus":0.07144568871647276,"score_gpt":0.40097600475699,"score_spread":0.32953031604051725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4207032141","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005122516,0.98655605,0.0009918743,0.003397602,0.00028086946,0.000031836375,0.000038514227,0.000015830708,0.0035649592],"genre_scores_gemma":[0.05050245,0.94314975,0.002163683,0.0021541587,0.0010324304,0.000046928828,0.0001150753,0.0000067620476,0.00082869985],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99937004,0.0002702084,0.00010538299,0.000047813297,0.00016187932,0.00004459053],"domain_scores_gemma":[0.9989827,0.0005473187,0.00022855078,0.000017954808,0.00017477066,0.000048607373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010565957,0.00024188645,0.0005440909,0.00077717635,0.00026054788,0.00071960845,0.00034350148,0.0006193069,0.0010016432],"category_scores_gemma":[0.0029291748,0.00008662206,0.00041523087,0.00059752556,0.00028203757,0.00079932495,0.00054814713,0.0008258648,0.0002449079],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028331025,0.000098701516,0.005708049,0.0157923,0.00021782228,0.0012473025,0.00035388782,0.0005640052,0.0020747783,0.0029328598,0.016861975,0.95386493],"study_design_scores_gemma":[0.00013517938,0.0013816374,0.024849873,0.02902836,0.0011055192,0.018187704,0.0010624483,0.0008296974,0.0048525734,0.0074478537,0.9110464,0.000072730036],"about_ca_topic_score_codex":0.00097082433,"about_ca_topic_score_gemma":0.0026144497,"teacher_disagreement_score":0.0010565957,"about_ca_system_score_codex":0.00061186287,"about_ca_system_score_gemma":0.0011939035,"threshold_uncertainty_score":0.005587876},"labels":[],"label_agreement":null},{"id":"W4313247961","doi":"10.2147/cmar.s340719","title":"Borderline Resectable Pancreatic Cancer: Challenges for Clinical Management","year":2022,"lang":"en","type":"review","venue":"Cancer Management and Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; FOLFIRINOX; Gemcitabine; Neoadjuvant therapy; Pancreatic cancer; Oncology; Radiation therapy; Adenocarcinoma; Pancreatic ductal adenocarcinoma; Chemotherapy; Randomized controlled trial; Clinical trial; Internal medicine; Cancer; Irinotecan; Breast cancer; Colorectal cancer","score_opus":0.5196987092176054,"score_gpt":0.5955855729175834,"score_spread":0.07588686369997799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313247961","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024789541,0.86536396,0.0038230084,0.121964715,0.0024754542,0.000048959824,0.00015870095,0.00007552452,0.0036107567],"genre_scores_gemma":[0.04588301,0.8970938,0.015381742,0.025242427,0.014658072,0.00017084429,0.0004667306,0.00005434494,0.0010490163],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972537,0.0012156384,0.00046665972,0.00028286182,0.0006452691,0.00013583007],"domain_scores_gemma":[0.9864883,0.00660348,0.0019479913,0.0003317461,0.0035177907,0.0011106218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006018485,0.000625305,0.0017729054,0.0015869038,0.0010172554,0.004039186,0.0014165909,0.0022775321,0.003025363],"category_scores_gemma":[0.01721593,0.00023498478,0.0009606676,0.0014737156,0.0016631869,0.00546123,0.0021820082,0.004937158,0.0015966797],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023483644,0.00012193173,0.005442777,0.0143834865,0.00019874715,0.0012137821,0.0005414939,0.0008679909,0.0008104063,0.006674255,0.10428255,0.86522776],"study_design_scores_gemma":[0.00018254184,0.00056431466,0.012722558,0.07015211,0.0006710983,0.013105659,0.007881183,0.0017530969,0.0005778719,0.070422634,0.8217096,0.0002573175],"about_ca_topic_score_codex":0.0013004241,"about_ca_topic_score_gemma":0.0029425763,"teacher_disagreement_score":0.006018485,"about_ca_system_score_codex":0.0015838719,"about_ca_system_score_gemma":0.004684872,"threshold_uncertainty_score":0.03182918},"labels":[],"label_agreement":null},{"id":"W4386482322","doi":"10.2147/cmar.s421675","title":"Pandemic-Induced Depression Among Older Adults with a History of Cancer During the COVID-19 Pandemic: Findings from the Canadian Longitudinal Study on Aging","year":2023,"lang":"en","type":"article","venue":"Cancer Management and Research","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Agency of Canada; University of Victoria; University of Toronto","funders":"Canadian Institutes of Health Research; Government of Canada; Public Health Agency; Public Health Agency of Canada; McMaster University","keywords":"Pandemic; Coronavirus disease 2019 (COVID-19); Depression (economics); 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Gerontology; Medicine; Longitudinal study; Virology; Disease; Infectious disease (medical specialty); Outbreak; Pathology","score_opus":0.2867641870913505,"score_gpt":0.47949359694838267,"score_spread":0.19272940985703219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386482322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99257386,0.0009940572,0.00007445997,0.00043643266,0.00002079131,0.00007676967,0.0044148206,0.0000043343375,0.0014043992],"genre_scores_gemma":[0.9960341,0.0007919003,0.000104990664,0.00018547663,0.000014254571,0.000031924206,0.0025201926,0.000002267599,0.00031498025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994079,0.000056355766,0.00004988817,0.000080297155,0.0002163077,0.00018921615],"domain_scores_gemma":[0.99835193,0.000073758885,0.00041753074,0.00007609139,0.0007228347,0.00035782126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009492745,0.0003087799,0.00034446435,0.0010727001,0.0015659492,0.0007582837,0.0010218399,0.0004746941,0.0010133866],"category_scores_gemma":[0.002930901,0.00026609274,0.0006494382,0.0021307617,0.00030045188,0.00033100776,0.000848265,0.0008325906,0.00014264212],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033557604,0.000015425025,0.99755967,0.000018000623,0.0000361603,0.000030380876,0.00034670698,0.000013531551,0.00003781675,0.000013828433,0.0004438998,0.0014509684],"study_design_scores_gemma":[0.0000022564848,0.0000063870634,0.9993556,0.000015403506,0.00001029117,0.00002207511,0.00037066714,0.00003348772,0.000005727533,0.000004087498,0.00017162175,0.0000024600874],"about_ca_topic_score_codex":0.9432814,"about_ca_topic_score_gemma":0.9645314,"teacher_disagreement_score":0.056718588,"about_ca_system_score_codex":0.004493616,"about_ca_system_score_gemma":0.006794912,"threshold_uncertainty_score":0.114105165},"labels":[],"label_agreement":null}]}